ANI Pharmaceuticals Inc (ANIP)
64.19
+1.37
(+2.18%)
USD |
NASDAQ |
Jun 25, 16:00
64.09
-0.10
(-0.16%)
After-Hours: 20:00
ANI Pharmaceuticals Research and Development Expense (TTM): 38.87M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 38.87M |
| December 31, 2023 | 34.29M |
| September 30, 2023 | 29.64M |
| June 30, 2023 | 26.18M |
| March 31, 2023 | 22.97M |
| December 31, 2022 | 22.32M |
| September 30, 2022 | 20.24M |
| June 30, 2022 | 15.04M |
| March 31, 2022 | 13.68M |
| December 31, 2021 | 11.37M |
| September 30, 2021 | 11.91M |
| June 30, 2021 | 12.40M |
| March 31, 2021 | 12.62M |
| December 31, 2020 | 16.00M |
| September 30, 2020 | 17.00M |
| June 30, 2020 | 19.04M |
| March 31, 2020 | 21.78M |
| December 31, 2019 | 19.81M |
| September 30, 2019 | 18.61M |
| June 30, 2019 | 18.30M |
| March 31, 2019 | 17.66M |
| December 31, 2018 | 15.39M |
| September 30, 2018 | 14.56M |
| June 30, 2018 | 12.52M |
| March 31, 2018 | 9.554M |
| Date | Value |
|---|---|
| December 31, 2017 | 9.07M |
| September 30, 2017 | 6.554M |
| June 30, 2017 | 4.961M |
| March 31, 2017 | 3.558M |
| December 31, 2016 | 2.906M |
| September 30, 2016 | 3.432M |
| June 30, 2016 | 3.206M |
| March 31, 2016 | 3.437M |
| December 31, 2015 | 2.874M |
| September 30, 2015 | 2.781M |
| June 30, 2015 | 2.849M |
| March 31, 2015 | 2.705M |
| December 31, 2014 | 2.678M |
| September 30, 2014 | 2.634M |
| June 30, 2014 | 2.205M |
| March 31, 2014 | 1.791M |
| December 31, 2013 | 2.387M |
| September 30, 2013 | 4.298M |
| June 30, 2013 | 7.716M |
| March 31, 2013 | 12.68M |
| December 31, 2012 | 16.89M |
| September 30, 2012 | 21.16M |
| June 30, 2012 | 28.78M |
| March 31, 2012 | 34.50M |
| December 31, 2011 | 44.18M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
11.37M
Minimum
Dec 2021
38.87M
Maximum
Mar 2024
20.10M
Average
18.82M
Median
Research and Development Expense (TTM) Benchmarks
| Ligand Pharmaceuticals Inc | 23.84M |
| ADMA Biologics Inc | 2.895M |
| Annovis Bio Inc | 37.52M |
| United Therapeutics Corp | 429.20M |
| Moderna Inc | 4.777B |